These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 8875561

  • 21. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B, Jang JS, Park K.
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [Abstract] [Full Text] [Related]

  • 22. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC.
    Cancer Res; 1997 Jul 01; 57(13):2668-75. PubMed ID: 9205075
    [Abstract] [Full Text] [Related]

  • 23. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM.
    Cell Growth Differ; 1990 Aug 01; 1(8):367-74. PubMed ID: 2177634
    [Abstract] [Full Text] [Related]

  • 24. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells.
    Turley JM, Fu T, Ruscetti FW, Mikovits JA, Bertolette DC, Birchenall-Roberts MC.
    Cancer Res; 1997 Mar 01; 57(5):881-90. PubMed ID: 9041190
    [Abstract] [Full Text] [Related]

  • 25. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 26. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.
    Koli K, Keski-Oja J.
    Cancer Res; 1995 Apr 01; 55(7):1540-6. PubMed ID: 7882362
    [Abstract] [Full Text] [Related]

  • 27. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 01; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 28. N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.
    Herbert BS, Sanders BG, Kline K.
    Nutr Cancer; 1999 Feb 01; 34(2):121-32. PubMed ID: 10578478
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M, Bicknell R, Harris AL.
    Cancer Res; 1992 Jan 15; 52(2):275-9. PubMed ID: 1728401
    [Abstract] [Full Text] [Related]

  • 30. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M.
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct 15; 283(4):G864-74. PubMed ID: 12223346
    [Abstract] [Full Text] [Related]

  • 31. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN, Sgagias MK.
    Clin Cancer Res; 1996 May 15; 2(5):827-35. PubMed ID: 9816237
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C, Sun L.
    Cancer Res; 1999 Oct 01; 59(19):5041-6. PubMed ID: 10519421
    [Abstract] [Full Text] [Related]

  • 34. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 35. RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells.
    Qian M, Sanders BG, Kline K.
    Nutr Cancer; 1996 Feb 01; 25(1):9-26. PubMed ID: 8837858
    [Abstract] [Full Text] [Related]

  • 36. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
    Zheng MH, Fan Y, Wysocki SJ, Lau AT, Robertson T, Beilharz M, Wood DJ, Papadimitriou JM.
    Am J Pathol; 1994 Nov 01; 145(5):1095-104. PubMed ID: 7977641
    [Abstract] [Full Text] [Related]

  • 37. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G, Ennis BW, Deschauer B, Katz D, Knabbe C, Wilding G, Daly P, Lippman ME, Dickson RB.
    J Cell Physiol; 1989 Nov 01; 141(2):353-61. PubMed ID: 2808542
    [Abstract] [Full Text] [Related]

  • 38. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols.
    Yu W, Simmons-Menchaca M, Gapor A, Sanders BG, Kline K.
    Nutr Cancer; 1999 Nov 01; 33(1):26-32. PubMed ID: 10227040
    [Abstract] [Full Text] [Related]

  • 39. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ.
    Cancer Res; 1995 Jun 01; 55(11):2380-6. PubMed ID: 7757990
    [Abstract] [Full Text] [Related]

  • 40. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB, Moody TW, Mariano JM.
    Anticancer Res; 1997 Jun 01; 17(3C):1849-60. PubMed ID: 9216635
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.